Research Progress of Epithelial-mesenchymal Transition Treatment and Drug Resistance in Colorectal Cancer

Colorectal cancer (CRC) is one of the most common malignancies in the world that seriously affects human health. Activation of epithelial-mesenchymal transition (EMT) is a physiological phenomenon during embryonic development that is essential for cell metastasis. EMT participates in various biologi...

Full description

Bibliographic Details
Main Authors: Qianyang Ni MD, Meng Li PhD, Suyang Yu PhD
Format: Article
Language:English
Published: SAGE Publishing 2022-04-01
Series:Technology in Cancer Research & Treatment
Online Access:https://doi.org/10.1177/15330338221081219
_version_ 1828275348017512448
author Qianyang Ni MD
Meng Li PhD
Suyang Yu PhD
author_facet Qianyang Ni MD
Meng Li PhD
Suyang Yu PhD
author_sort Qianyang Ni MD
collection DOAJ
description Colorectal cancer (CRC) is one of the most common malignancies in the world that seriously affects human health. Activation of epithelial-mesenchymal transition (EMT) is a physiological phenomenon during embryonic development that is essential for cell metastasis. EMT participates in various biological processes associated with trauma repair, organ fibrosis, migration, metastasis, and infiltration of tumor cells. EMT is a new therapeutic target for CRC; however, some patients with CRC develop resistance to some drugs due to EMT. This review focuses specifically on the status of treatments that target the EMT process and its role in the therapeutic resistance observed in patients with CRC.
first_indexed 2024-04-13T06:47:13Z
format Article
id doaj.art-0d4e6dc4c745453cb7e07eba3a05650e
institution Directory Open Access Journal
issn 1533-0338
language English
last_indexed 2024-04-13T06:47:13Z
publishDate 2022-04-01
publisher SAGE Publishing
record_format Article
series Technology in Cancer Research & Treatment
spelling doaj.art-0d4e6dc4c745453cb7e07eba3a05650e2022-12-22T02:57:32ZengSAGE PublishingTechnology in Cancer Research & Treatment1533-03382022-04-012110.1177/15330338221081219Research Progress of Epithelial-mesenchymal Transition Treatment and Drug Resistance in Colorectal CancerQianyang Ni MD0Meng Li PhD1Suyang Yu PhD2 Department of Gastrointestinal Surgery, , Shijiazhuang, China Meng Li has become the co-first author due to his outstanding contribution Department of Gastrointestinal Surgery, , Shijiazhuang, China Colorectal cancer (CRC) is one of the most common malignancies in the world that seriously affects human health. Activation of epithelial-mesenchymal transition (EMT) is a physiological phenomenon during embryonic development that is essential for cell metastasis. EMT participates in various biological processes associated with trauma repair, organ fibrosis, migration, metastasis, and infiltration of tumor cells. EMT is a new therapeutic target for CRC; however, some patients with CRC develop resistance to some drugs due to EMT. This review focuses specifically on the status of treatments that target the EMT process and its role in the therapeutic resistance observed in patients with CRC.https://doi.org/10.1177/15330338221081219
spellingShingle Qianyang Ni MD
Meng Li PhD
Suyang Yu PhD
Research Progress of Epithelial-mesenchymal Transition Treatment and Drug Resistance in Colorectal Cancer
Technology in Cancer Research & Treatment
title Research Progress of Epithelial-mesenchymal Transition Treatment and Drug Resistance in Colorectal Cancer
title_full Research Progress of Epithelial-mesenchymal Transition Treatment and Drug Resistance in Colorectal Cancer
title_fullStr Research Progress of Epithelial-mesenchymal Transition Treatment and Drug Resistance in Colorectal Cancer
title_full_unstemmed Research Progress of Epithelial-mesenchymal Transition Treatment and Drug Resistance in Colorectal Cancer
title_short Research Progress of Epithelial-mesenchymal Transition Treatment and Drug Resistance in Colorectal Cancer
title_sort research progress of epithelial mesenchymal transition treatment and drug resistance in colorectal cancer
url https://doi.org/10.1177/15330338221081219
work_keys_str_mv AT qianyangnimd researchprogressofepithelialmesenchymaltransitiontreatmentanddrugresistanceincolorectalcancer
AT mengliphd researchprogressofepithelialmesenchymaltransitiontreatmentanddrugresistanceincolorectalcancer
AT suyangyuphd researchprogressofepithelialmesenchymaltransitiontreatmentanddrugresistanceincolorectalcancer